DOJ Recovered $900 Million From FCA Violators in Pharma Last Year

Drug Industry Daily
A A
The Justice Department recovered more than $900 million from medical product manufacturers relating to False Claims Act violations in fiscal 2017, down from $1.2 billion in 2016.

To View This Article:

Login

Subscribe To Drug Industry Daily